- The Hong Kong stock market closed higher on August 20, with the Hang Seng Index up 203 pts or 0.8% at 25,698 and a total turnover of HKD 269.119 billion.
- KUAISHOU-W plunged 11.01% as its 2Q adjusted profit slid 30.3% YoY, while SBP GROUP surged 12.53% following a better-than-expected interim profit report.
- mRNA concept stocks rallied significantly after Moderna's cancer vaccine breakthrough, driving strong gains in related pharmaceutical firms like EVEREST MED and CANSINOBIO.
- Hong Kong stocks closed higher at midday on August 20, 2026, with the Hang Seng Index up 291 points or 1.14% at 25,786.
- The morning session featured significant market movements, including a 9.74% slump in Kuaishou-W following weak results and a 16.18% surge in Sbp Group driven by strong interim profit.
- Innovative drug and gold mining stocks rallied broadly, supported by external pharmaceutical clinical trial breakthroughs and spot gold prices breaking above USD4,500 per ounce.